Key facts
- 52-week range (closes)
- $244.41 – $309.18 Lowest close Oct 31, 2025, highest Oct 27, 2025; 251 daily closes to Oct 13, 2026 from Dalsna Finance's price archive
- Fiscal year ends
- December Fiscal 2025 ended Dec 31, 2025, from SEC filings
- In the S&P 500 since
- Jun 30, 1976 · All S&P 500 changes
- Analyst coverage
- 1 open price target from 1 firm: UBS Approved targets tracked here; see the analyst section below
Cigna (CI) is trading up at $306.60 (+2.71%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Health Care sector.
Analyst price targets on CI
One firm's current price target on Cigna: $400 — 30% above the current $307. Each is tracked to its date and scored the same way a member's call is.
- UBS $268 → $400 by Oct 2027 Oct 1, 2026 via Investing.com · UBS's track record
Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.
Cigna revenue & net income history (FY2016–FY2025)
| FY2016Dec 2016 | FY2017Dec 2017 | FY2018Dec 2018 | FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $39.8B | $41.8B | $48.6B | $153.6B | $160.4B | $174.1B | $180.5B | $195.3B | $247.1B | $274.9B |
| Growth (year over year) | — | +4.9% | +16.4% | +215.7% | +4.5% | +8.5% | +3.7% | +8.2% | +26.6% | +11.2% |
| Gross profit | $37.4B | $39.4B | $43.9B | $55.9B | $56.9B | $56.5B | $55.7B | $61.5B | $64.6B | $59.9B |
| Gross margin | 93.8% | 94.1% | 90.1% | 36.4% | 35.5% | 32.5% | 30.8% | 31.5% | 26.1% | 21.8% |
| Operating income | $3.09B | $3.94B | $4.16B | $8.08B | $8.15B | $7.94B | $8.45B | $8.54B | $9.42B | $9.20B |
| Operating margin | 7.8% | 9.4% | 8.6% | 5.3% | 5.1% | 4.6% | 4.7% | 4.4% | 3.8% | 3.3% |
| Net income | $1.87B | $2.24B | $2.64B | $5.10B | $8.46B | $5.37B | $6.70B | $5.16B | $3.43B | $5.96B |
| Net margin | 4.7% | 5.4% | 5.4% | 3.3% | 5.3% | 3.1% | 3.7% | 2.6% | 1.4% | 2.2% |
| EPS (diluted) | $7.19 | $8.77 | $10.54 | $13.44 | $22.96 | $15.75 | $21.41 | $17.39 | $12.12 | $22.18 |
| Balance sheet | ||||||||||
| Cash and equivalents | $3.19B | $2.97B | $3.85B | $4.62B | $10.2B | $5.08B | $5.92B | $7.82B | $7.55B | $7.68B |
| Total assets | — | $61.8B | $153.2B | $155.8B | $155.5B | $154.9B | $143.9B | $152.8B | $155.9B | $157.9B |
| Total liabilities | — | $48.0B | $112.2B | $110.4B | $105.1B | $107.7B | $99.1B | $106.4B | $114.6B | $116.0B |
| Long-term debt | — | $5.20B | $39.5B | $31.9B | $29.5B | $31.1B | $28.1B | $28.2B | $28.9B | $30.9B |
| Shareholders' equity | $13.7B | $13.7B | $41.0B | $45.3B | $50.3B | $47.1B | $44.7B | $46.2B | $41.0B | $41.7B |
| Cash flow | ||||||||||
| Operating cash flow | $4.03B | $4.09B | $3.77B | $9.48B | $10.3B | $7.19B | $8.66B | $11.8B | $10.4B | $9.60B |
| Capital expenditure | $461.0M | $471.0M | $528.0M | $1.05B | — | — | — | — | — | — |
| Free cash flow | $3.56B | $3.62B | $3.24B | $8.44B | — | — | — | — | — | — |
| Dividends paid | — | — | — | $15.0M | $15.0M | $1.34B | $1.38B | $1.45B | $1.57B | $1.61B |
| Share buybacks | $139.0M | $2.73B | $342.0M | $1.99B | $4.04B | $7.74B | $7.61B | $2.28B | $7.03B | $3.62B |
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $63.7B | $65.6B | $65.5B | $67.2B | $69.7B | $72.5B | $68.5B | $71.7B |
| Growth (year over year) | +29.9% | +28.4% | +14.4% | +11.0% | +9.5% | +10.4% | +4.6% | +6.7% |
| Gross profit | $16.1B | $16.6B | $17.1B | $13.9B | $14.2B | $14.7B | $14.4B | $15.0B |
| Gross margin | 25.3% | 25.3% | 26.1% | 20.7% | 20.4% | 20.3% | 21.0% | 20.9% |
| Operating income | $2.58B | $2.17B | $1.97B | $2.31B | $2.58B | $2.35B | $2.36B | $2.68B |
| Operating margin | 4.0% | 3.3% | 3.0% | 3.4% | 3.7% | 3.2% | 3.4% | 3.7% |
| Net income | $739.0M | $1.42B | $1.32B | $1.53B | $1.87B | $1.23B | $1.65B | $1.66B |
| Net margin | 1.2% | 2.2% | 2.0% | 2.3% | 2.7% | 1.7% | 2.4% | 2.3% |
| EPS (diluted) | $2.63 | $5.01 | $4.85 | $5.71 | $6.98 | $4.64 | $6.26 | $6.29 |
| Balance sheet | ||||||||
| Cash and equivalents | $5.89B | $7.55B | $8.33B | $4.33B | $6.03B | $7.68B | $7.04B | $6.30B |
| Total assets | $157.6B | $155.9B | $150.7B | $151.7B | $157.9B | $157.9B | $153.3B | $157.1B |
| Total liabilities | $115.3B | $114.6B | $110.2B | $111.2B | $115.9B | $116.0B | $110.8B | $114.2B |
| Long-term debt | $30.2B | $28.9B | $26.5B | $26.5B | $30.9B | $30.9B | $29.4B | $29.1B |
| Shareholders' equity | $42.1B | $41.0B | $40.2B | $40.2B | $41.8B | $41.7B | $42.2B | $42.6B |
| Cash flow | ||||||||
| Operating cash flow | $46.0M | $5.21B | $1.92B | −$1.89B | $3.42B | $6.15B | $1.13B | −$421.0M |
| Dividends paid | $390.0M | $384.0M | $412.0M | $401.0M | $402.0M | $396.0M | $417.0M | $409.0M |
| Share buybacks | $0 | $2.02B | $1.51B | $1.11B | $0 | $1.00B | $0 | $280.0M |
From Cigna's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
Cigna vs the Health Care sector and the S&P 500
Cigna's latest reported figures next to the median of the other 59 S&P 500 Health Care companies and of the other 502 S&P 500 companies; each median is taken over the companies with a comparable figure (counts in the footnote). A median is the middle value, not an average, so one very large company does not move it.
| Measure | Cigna | Health Care (59 other S&P 500 companies) | S&P 500 (502 other companies) |
|---|---|---|---|
| Revenue growth, latest fiscal year | +11.2% | +7.1% | +7.0% |
| Net margin, latest fiscal year | 2.2% | 13.1% | 13.0% |
| Dividend per share, latest fiscal year | $6.04 | $2.43 | $2.40 |
| Share price change, 1 year | −0.1% | +22.8% | +7.5% |
Cigna: fiscal year ended December 2025, from its 10-K and 10-Q filings with the SEC. Medians computed October 20, 2026 from each company's latest annual filing (fiscal years ending between July 2025 and September 2026) and our price archive. Prices for every company, Cigna included, are the last regular-session prices of October 20, 2026; the 1-year change compares that price with each company's last close on or before October 20, 2025. Net margin and price change are our calculations from reported figures. Each median counts only the companies with a comparable figure (sector / S&P 500): revenue growth 59/496, net margin 59/496, dividend per share 32/349, 1-year price change 59/488; the reasons below can overlap. 14 are left out of the price figure because our archive holds no comparable close for them; dividend medians are among the 32 sector and 349 S&P 500 companies reporting a per-share dividend. The S&P 500 price figure is the middle company's change, not the index's return.
About Cigna
The Cigna Group is an American multinational for-profit managed healthcare and insurance company based in Bloomfield, Connecticut. Cigna's insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups.
Source: Wikipedia — The Cigna Group
- Headquarters
- Bloomfield, Connecticut From SEC filings, Oct 2026
Recent News (20)
-
The Cigna Group's Third Quarter 2026 Earnings Release Details BLOOMFIELD, Conn., Oct. 9, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its third quarter 2026 financial results on Thursday, November 5, 2026, and will host a con…
-
Cigna Healthcare Introduces Health Sense To Connect Guidance, Benefits and Clinical Support Around Each Person, Improving Affordability and Outcomes By connecting information about each person's health, care and coverage, Health Sense℠ helps people receive continuous personalized support, make informed decisions and act sooner Projected to reduce …
-
-
UBS reiterates Cigna stock buy rating on 2026-2030 outlook
UBS reiterates Cigna stock buy rating on 2026-2030 outlook
-
Cigna options flow turns bullish even as technicals signal sell
Cigna options flow turns bullish even as technicals signal sell
-
-
-
Can Cigna's AI Push Help Rein In Rising Healthcare Costs? Can Cigna's AI Push Help Rein In Rising Healthcare Costs? The Globe and Mail
-
Is Volunteering Good for Your Health? New Research From The Cigna Group Finds a Strong Connection The Cigna Group's Vitality in America report finds people who volunteer feel healthier, more connected, and more resilient Research links employee volunteerism to higher job satisfaction, workplace pr…
-
Cigna Group Executive Neville Everett Sells 617 Shares for $175,000
Cigna Group Executive Neville Everett Sells 617 Shares for $175,000
-
The Cigna Group to Host Investor Day on September 30 BLOOMFIELD, Conn., Sept. 9, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) will host its Investor Day on Wednesday, September 30, 2026. The event will begin at 8:30 a.m. ET, fea…
-
How Is The Cigna Group’s Stock Performance Compared to Other Healthcare Plans
How Is The Cigna Group’s Stock Performance Compared to Other Healthcare Plans
-
-
-
Cigna: I'm Buying What Others Are Ignoring (NYSE:CI) Cigna: I'm Buying What Others Are Ignoring (NYSE:CI) Seeking Alpha
-
Are Wall Street Analysts Bullish on Cigna Group Stock?
Are Wall Street Analysts Bullish on Cigna Group Stock?
-
Cigna Beat Earnings and Raised Guidance. Why the Stock Is Dropping. Cigna Beat Earnings and Raised Guidance. Why the Stock Is Dropping.
-
-
Why is Cigna stock slipping today?
Why is Cigna stock slipping today?
-
More Health Care stocks
- BIIB Biogen
- BMY Bristol Myers Squibb
- BSX Boston Scientific
- CAH Cardinal Health
- CNC Centene Corporation
- COO Cooper Companies (The)
- COR Cencora
- CRL Charles River Laboratories